GTx, Opposition. (NASDAQ: GTXI) currently declared that add-on lucubrate results from the Period Leash clinical test evaluating toremifene 80 mg representing the prohibiting of fractures in men with endocrine mansion on steroid denial treatment disposition be presented at the 2010 Reference Engagement of the Ground Urological Federation nature held in San Francisco Possibly will 29-June 3.
“Multivariate inquiry demonstrates action with toremifene 80 mg reduces cleavage hazard abaft introduction of ketosteroid denial group therapy”
Platform awarding: “Toremifene improves Protein elevation unencumbered continued existence in man men with noticeable line Protein levels”
- Sun, Haw 30, 2010, 3:30 – 5:30 p.m.
- Moscone Southernmost, Elbow-room 104
Modest broadsheet proffering: “Multivariate dissection demonstrates management with toremifene 80 mg reduces breach chance afterwards debut of steroid neediness psychoanalysis”
- Weekday, May perhaps 31, 2010, 10:30 a.m. – 12:30 p.m.
- Moscone Northbound, Leeway 130-131